Abstract
For Enterobacteriaceae such as Salmonella spp. and Escherichia coli, no unified interpretive resistance criteria exist for streptomycin, an epidemiologically important antibiotic. As part of the National Antimicrobial Resistance Monitoring System, we had previously used a minimum inhibitory concentration of ≥ 64 μg mL(-1) as an epidemiological cutoff value (ECV) to define non-wild-type isolates. To identify whether this ECV correlated with genetic determinants of resistance, we performed whole-genome sequencing of 463 Salmonella and E. coli isolates to identify streptomycin resistance genotypes. From this analysis, we found that using a streptomycin resistance breakpoint of ≥ 64 μg mL(-1) classified over 20% of strains possessing aadA or strA/strB resistance genes as wild-type. Therefore, to improve the concordance between genotypic and phenotypic data, we propose reducing the phenotypic cutoff values to ≥ 32 μg mL(-1) for both Salmonella and E. coli, to be used widely as ECVs to categorize non-wild-type isolates.
References
Feb 20, 1989·Gene·P ScholzE Scherzinger
Jan 1, 1985·Plasmid·S Hollingshead, D Vapnek
Feb 1, 1996·Molecular Ecology·G W Sundin, C L Bender
Aug 26, 1998·The American Journal of Cardiology·W R Daley
Feb 13, 1999·Journal of Clinical Microbiology·C D StewardF C Tenover
Apr 2, 1999·Antimicrobial Agents and Chemotherapy·M P Mingeot-LeclercqP M Tulkens
Apr 18, 2001·EMBO Reports·E C BöttgerP Sander
May 18, 2005·The Journal of Antimicrobial Chemotherapy·Marianne Sunde, Madelaine Norström
Apr 11, 2006·Foodborne Pathogens and Disease·S ZhaoD G White
Apr 29, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J TurnidgeG Kronvall
May 18, 2006·International Journal of Antimicrobial Agents·Geraldine DoranMartin Cormican
Nov 16, 2010·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Po-Ren HsuehLee-Jene Teng
Dec 2, 2010·Zoonoses and Public Health·A DeckertR Irwin
Jul 14, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Lourdes Garcia-MiguraFrank M Aarestrup
Sep 12, 2012·Comparative Immunology, Microbiology and Infectious Diseases·Yuan-Man HsuChao-Chin Chang
May 15, 2015·Journal of Clinical Microbiology·Katrine G JoensenFlemming Scheutz
Jul 5, 2015·The Journal of Antimicrobial Chemotherapy·Gregory H TysonShaohua Zhao
Citations
Jan 18, 2017·Expert Review of Molecular Diagnostics·W Michael DunneAlex Van Belkum
May 24, 2018·Genes·Elena A OniciucAvelino Alvarez-Ordóñez
Jul 7, 2016·Antimicrobial Agents and Chemotherapy·Patrick F McDermottShaohua Zhao
Jan 1, 2019·PloS One·Vaishnavi PattabiramanEija Trees
Jan 24, 2019·Microbiology·Andrea B KeeferEdward G Dudley
Jul 4, 2019·BMC Microbiology·Nana MensahLiljana Petrovska-Holmes
Sep 15, 2019·Applied and Environmental Microbiology·Gizem LeventH Morgan Scott
Aug 7, 2019·Antimicrobial Agents and Chemotherapy·Ying-Shu LiaoChien-Shun Chiou
Aug 21, 2019·Antimicrobial Agents and Chemotherapy·Michael FeldgardenWilliam Klimke
Jul 3, 2020·PloS One·Zhao ChenJianghong Meng
Apr 23, 2020·Frontiers in Microbiology·Ashley L CooperCatherine D Carrillo
May 27, 2020·PloS One·Ishmael Festus JajaEzekiel Green
Jun 1, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Chih-Hao HsuShaohua Zhao
Sep 14, 2019·FEMS Microbiology Letters·Erjie TianJichang Li
Dec 21, 2016·Antimicrobial Agents and Chemotherapy·Gregory H TysonPatrick F McDermott
Feb 5, 2021·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Qi FengGanwu Li
Nov 22, 2020·Antibiotics·Mohamed Tarek BadrGeorg Häcker
Apr 18, 2021·Applied and Environmental Microbiology·Gizem LeventH Morgan Scott
Jul 14, 2018·Microbiology Spectrum·S SimjeeR Chuanchuen
May 21, 2021·Journal of Food Protection·Heather TatePatrick F McDermott